EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies

Sunyoung Lee, Ji Hyun Kim iD, In-Hwan Jang, Seona Jo, Soo Yun Lee, Se-Chan Oh iD, Seok-Min Kim, Lingzu Kong, Jesang Ko iD, Tae-Don Kim iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910326 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sunyoung Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cell and Gene Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea. Hauptthemen laut MEDLINE: Neoplasms, B7 Antigens, Immunotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Science & Technology(NST) grant, National Research Foundation grant, National Research Council of Science & Technology(NST).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer therapies have evolved from traditional chemotherapy to more precise molecular-targeted immunotherapies, which have been associated with improved side effects and outcomes. These modern strategies rely on cancer-specific biomarkers that differentiate malignant from normal cells. The B7 family of immune checkpoint molecules is crucial for cancer immune evasion and a prime therapeutic target. B7-H6, a recently identified member of the B7 family, has emerged as a promising therapeutic target. Unlike other B7 proteins, B7-H6 is not expressed in healthy tissues but is upregulated in several cancers. It binds to NKp30, activating natural killer (NK) cells and triggering immune responses against cancer cells. This review explores the expression of B7-H6 in different cancers, the factors that regulate its expression, and its intrinsic and extrinsic pathways. Additionally, we discuss potential anticancer therapies targeting B7-H6, highlighting its significance in advancing precision medicine. Understanding the role of B7-H6 in cancer immunity may inform the development of appropriate therapies that exploit its cancer-specific expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsB7 AntigensImmunotherapyHumansGene Expression Regulation, NeoplasticAnimalsKiller Cells, NaturalNatural Cytotoxicity Triggering Receptor 3Signal TransductionBiomarkers, Tumor

Stichwörter der Autor:innen

B7-H6NKp30cancer-specific targettargeted therapy

Substanzen

B7 AntigensNCR3LG1 protein, humanNatural Cytotoxicity Triggering Receptor 3NCR3 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Center for Cell and Gene Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea.
  • Division of Life Sciences, Korea University, Seoul 02841, Republic of Korea.
  • KRIBB School of Bioscience, Korea University of Science and Technology (UST), Daejeon 34113, Republic of Korea.
  • Department of Biochemistry, College of Natural Sciences, Chungnam National University, Daejeon 34134, Republic of Korea.

ORCID-Profile: Ji Hyun Kim, Se-Chan Oh, Jesang Ko, Tae-Don Kim

Förderung

  • National Research Council of Science & Technology(NST) grant
  • National Research Foundation grant
  • National Research Council of Science & Technology(NST)
  • National Research Foundation
  • KRIBB Initiative Program

Zitieren

APA

Lee, S., Kim, J. H., Jang, I. H., Jo, S., Lee, S. Y., Oh, S. C., Kim, S. M., Kong, L., Ko, J., & Kim, T. D. (2024). Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910326

Vancouver

Lee S, Kim JH, Jang IH, Jo S, Lee SY, Oh SC, et al. Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910326

BibTeX
@article{Lee2024,
  author = {Lee, Sunyoung and Kim, Ji Hyun and Jang, In-Hwan and Jo, Seona and Lee, Soo Yun and Oh, Se-Chan and Kim, Seok-Min and Kong, Lingzu and Ko, Jesang and Kim, Tae-Don},
  title = {Harnessing B7-H6 for Anticancer Immunotherapy: Expression, Pathways, and Therapeutic Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910326}
}
Kostenlos starten →